FREE Account Opening + No Clearing Fees
Loading...
June 23, 2022 - July 6, 2022

Zydus Lifesciences Limited Buyback (Zydus Lifesciences Buyback) Detail

Zydus Lifesciences Limited is a leading Indian Pharmaceutical company that offers healthcare services globally. The company manufactures formulations, APIs, vaccines, biosimilars, complex products (transdermals, topical etc.), animal health products as well as wellness products.

Zydus Lifesciences Limited has more than 30 manufacturing plants worldwide including India, Germany, Brazil & USA. Zydus Lifesciences Limited is the fourth largest pharmaceutical company in India. Zydus Lifesciences was formerly known as Cadila Healthcare Limited.

Zydus Lifesciences Buyback Detail

Issue PeriodJune 23, 2022 - July 6, 2022
Security NameZydus Lifesciences Limited
Issue TypeTender Offer
Issue Size (Shares)11,538,461
Issue Size (Amount)₹750.00 Crores
Buyback Price₹650 per share
Face Value₹1 per share
Listing AtBSE, NSE

Zydus Lifesciences Buyback Issue Timetable

Record DateJune 2, 2022
Offer Opens OnJune 23, 2022
Last Date for receipt of Tender FormsJuly 6, 2022
Offer Closes On *July 6, 2022
Finalisation of Buyback AcceptanceJuly 14, 2022
Last Date for settlment of bidsJuly 15, 2022
Last Date for Extinguishment of SharesJuly 22, 2022

Buyback Ratio

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 26 Equity Share out of every 503 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 101 Fully paid-up Equity Shares held on the Record Date.

Company Financials

Summary of financial Information (Consolidated)
Particulars For the year/period ended (Rs. in Million)
  31-Mar-22 31-Mar-21 31-Mar-20
Total Income 1,54,899 1,51,394 1,43,670
Profit After Tax 23,726 21,850 12,044
Net Worth 1,69,996 1,29,923 1,03,757

Stock price at BSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 376.60 337.70 359.37
Mar-2022 379.00 331.00 359.62
Feb-2022 420.50 343.00 385.95

Stock price at NSE (in preceding 3 months)

Month High Price Low Price Average Price
Apr-2022 376.70 337.55 359.43
Mar-2022 378.60 331.55 359.63
Feb-2022 420.55 342.85 385.99

Necessity of the Issue

The buyback is being undertaken for the following reason:

1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity.

Zydus Lifesciences Buyback Documents

Zydus Lifesciences Buyback Rating

45
4.3
Rating:Rated 4.3 stars
Vote Here ...

Zydus Lifesciences Buyback Reviews

Sorry, we couldn't find any reviews, please check back later.

Company Contact Information

Zydus Lifesciences Limited
Zydus Corporate Park, Scheme No. 63,
Khoraj (Gandhinagar), 536, Sarkhej-Gandhinagar Hwy
Near Vaishnodevi Circle, Ahmedabad, 382481

Phone: +91-79-71800000
Email: dhavalsoni@zyduslife.com
Website: https://www.zyduslife.com/index

Zydus Lifesciences Buyback Registrar

  1. Link Intime India Private Ltd
       Link Intime India Private Ltd
       C 101, 247 Park, L.B.S.Marg,
       Vikhroli (West), Mumbai - 400083

    Phone: +91-22-4918 6270
    Email: zyduslife.buyback2022@linkintime.co.in
    Website: https://linkintime.co.in/initial_offer/public-issues.html

Zydus Lifesciences Buyback Manager

Lead Manager(s)

  1. ICICI Securities Limited

Registered Broker

  1. ICICI Securities Limited
    Email: sumitkumar.singh@icicisecurities.com

Find Zydus Lifesciences Buyback Latest Update

Zydus Lifesciences Buyback FAQs

The Zydus Lifesciences Buyback opens on June 23, 2022, and closes on July 6, 2022.

The Zydus Lifesciences Buyback last day to buy is not available as of now.

The Zydus Lifesciences Buyback is a Tender Offer.

Zydus Lifesciences Buyback Schedule

Buyback Opening DateJune 23, 2022
Buyback Closing DateJuly 6, 2022
Last Date for receipt of Tender FormsJuly 6, 2022
Finalisation of Buyback AcceptanceJuly 14, 2022
Last Date for settlment of bidsJuly 15, 2022
Last Date for Extinguishment of SharesJuly 22, 2022

The Zydus Lifesciences Buyback is being offered at Rs ₹650 per share per equity share.

Category Entitlement Ratio of Buyback
Reserved Category for Small Shareholders 26 Equity Share out of every 503 Fully paid-up Equity Shares held on the Record Date.
General Category for all other Eligible Shareholders 1 Equity Shares out of every 101 Fully paid-up Equity Shares held on the Record Date.

The record date for the Zydus Lifesciences Buyback is June 2, 2022.

The issue size of Zydus Lifesciences Buyback is of 11,538,461 equity shares at ₹650 per share aggregating upto ₹750.00 Crores.

The buyback is being undertaken for the following reason:

1. The Buyback will help the Company to distribute a part of the surplus cash to its shareholders holding Equity Shares thereby, optimizing returns to the shareholders and enhancing the overall shareholders' value in longer term and improving the return on equity.

All the eligible Shareholders of the Company holding either Physical Shares or Demat Shares as on the Record Date can participate in the buyback offer through their Stock Broker.

The eligible shareholder holding the shares in Demat form needs to inform their broker the details of the Equity shares they wish to tender in the Buyback Offer. The shareholder needs to transfer the tendered shares to a Special account of the clearing corporation. The broker, in turn, would place an order on the stock exchange for the buyback.

The eligible shareholder holding the shares in physical form needs to approach their broker with original share certificates and supporting documents. Upon completion of document verification, the broker places an order on the stock exchange and submits the original share certificate and TRS to the registrar.

The tender form and TRS are optional in the case of Demat shares but mandatory in the case of physical shares.

The Zydus Lifesciences Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.


56 Comments

16. Harshit Bhasin     Link|June 6, 2022 9:29:11 AM
What is the target price for june
15. Gurubhai     Link|June 2, 2022 8:30:12 AM
On June 1, I sold the 500 shares I was holding. Can I buy some back before the last tender date and offer them in the buyback ? Will the number of shares accepted depend on the number of shares offered or only on the number of shares held on the record date ? In other words will it make any difference to the number of shares accepted from me if I offer 50 vs 100 shares ?
15.1. Mohsin     Link|June 2, 2022 12:51:19 PM
1. You can buy later when tender dates announce.
2. Number of shares to accept depends on holdings on record date.
14. Dilip Vengar     Link|June 2, 2022 10:20:05 AM
Have 180 Zydus shares bought through HDFC Sec, never done buyback. Is this available through HDFC itself?
13. MAHESH NARESH     Link|June 1, 2022 8:45:14 PM
I am having 612 shares of Zydus Life worth more then 2 Lakhs, may I tender shares to buyback process?
13.1. Prashant Khandelwal     Link|June 2, 2022 12:35:43 AM
You can tender shares but not in retail category shareholders
12. Samrat     Link|June 1, 2022 1:57:14 PM
I have 370 shares of Zydus Lifescience at price of Rs.610.11 per share. How many shares can I apply for buyback? Is there any limit for retail category like 2 lac amount?
Detailed answer for the query is highly appreciated. Thanks.
12.1. Mohsin     Link|June 1, 2022 6:36:02 PM
1. You will get mail from company about entitlement ratio. Around 20-25 june.
Thn you can apply in buyback in tender dates.
We can expect ER-AR 8-15%.
So as per your holdings 370 shares you get mail soon. You can tender all 370 shares.
May be 35-60 shares accept. ( If more thn good ).
Yes Retail holding under 2 lakh.

I m holding 500 and 400 shares in two accounts.

You will eligible to tender as small retail holders quota. ( 378 × 370 = 1,40,000 approx )
11. Rookie     Link|June 1, 2022 9:50:05 AM
Is it too late to buy today?
11.1. KAMMA SIVA RAMA KRISHNA     Link|June 1, 2022 12:07:26 PM
Yes
10. Sujoy Banerjer     Link|May 31, 2022 12:05:50 PM
I have 37 shares of zyduslife bought 6 months earlier.....how many of these are likely to be accepted if tendered fully?
10.1. Ramesh.bg     Link|May 31, 2022 9:43:02 PM
We will get more clarity when ER and AR are known. I guess AR may be around 10 to 15%. So, may be around 3 to 5 shares out of 37 may be accepted in buyback.. Just my assumption..
9. FAROOK D     Link|May 31, 2022 11:49:12 AM
how much minimum shares to buy from ourside so that they can accept our buyback or any minimum limit of shares to buy ?
8. Kumar M     Link|May 31, 2022 7:39:26 AM
If I have purchased shares as on 31-05-2022, can i be eligible for buyback
8.1. Ramesh.bg     Link|May 31, 2022 10:36:37 AM
Yes.. eligible.. buy on 31st (as record date is 2nd June). But, advisable to buy minimum quantity as heavy selling may be there tomorrow 1st June which of the ex date.
7. Ramesh.bg     Link|May 30, 2022 3:08:17 PM
Hope AR will be very low and not advisable to buy at current price of 375 levels. 1st June being ex date, heavy selling may be there on ex date which will bring the price to 350 levels.
6. lala paisewala     Link|May 27, 2022 9:26:54 AM
zydus buy back 2 lakh rs / 45 days / 5000 fix profit
6.1. kunal     Link|May 30, 2022 2:21:57 PM
i want to sell
5. ganesh jaiswal     Link|May 20, 2022 10:54:15 PM
Total retail quota in buy back 17 lamha shares.

Share present held by retail investors approach 2 Crore.

So only 2.5% share of retail share holders acceptance.

Very poor chances of acceptance
5.4. Gopu     Link|May 25, 2022 9:31:50 PM
@ganesh and @Mohsin

Is it 7 crore shares under 2 lakh market value or face value? If it is market value according to company PDF only 10 noninstitutional investors have more than 2 lakhs, which is absurd for a 37K crore company. I think it should be FV, right?

If you look at TCS shareholding pattern on BSE only 7 people have more than 2 lakhs. Has to be FV, because 2 lakhs se zyada TCSme to Dadar Station me hi 100-150 log mil jayenge. :D

Experts please help! Is there a way to approximately know how many people hold less than 2 lakh market value in a stock?
5.5. Nkparwal     Link|May 30, 2022 12:04:36 PM
No one knows how much shares are in retail category holders. Because company gives list of share holders valuing as per face value. Only registrar knows. Ex buy back date is 1st June, so new share holders will be added till then
4. A G PUJARI     Link|May 24, 2022 8:57:07 AM
Please can any one clarify whether Birla Soft buy Back is on Tender Offer basis or Open Market offer ?
4.1. KAMMA SIVA RAMA KRISHNA     Link|May 24, 2022 11:09:42 AM
Through Tender Offer.
3. Vipin     Link|May 21, 2022 2:01:49 PM
If i purchase one share only then what are chances of buy back. Will one share will come under the category of buy back by the company. Please suggest
2. Mohsin patel     Link|May 21, 2022 12:08:08 PM
Respected sirs & experts.
How much can we expect Retails ER-AR in Zydus and matrimony buyback.
I got following information from previous buyback.
1. TCS
Retails share buyback quota : 4.18%
ER : 13-14%
AR : 22-23%

2. Gail
Retails share buyback quota : 4.89%
ER : 8%
AR : soon

3. Matrimony
Retails share buyback quota : 6.61%
ER-AR : ?

4. Zydus life science
Retails share buyback quota : 2.50%
ER-AR : ?

Thanks.
1. Smile.     Link|May 20, 2022 9:26:35 PM
Looking big but number of retail shareholder is huge, Looking at offer all may participate so Acceptance Ratio will be very less.

Compare Buybacks with Zydus Lifesciences Buyback